ArticleDermatology and therapy2025

Long-Term Integrated Safety Summary of Ruxolitinib Cream in Phase 3 Clinical Trials of Patients with Vitiligo.

David Rosmarin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.